Vistagen Therapeutics (VTGN) Other Gross PP&E Adjustments (2017 - 2025)
Vistagen Therapeutics (VTGN) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with -$939000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 35.73% to -$939000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$939000.0 through Dec 2025, up 35.73% year-over-year, with the annual reading at -$2.5 million for FY2025, 19.3% up from the prior year.
- Other Gross PP&E Adjustments hit -$939000.0 in Q4 2025 for Vistagen Therapeutics, up from -$1.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.7 million in Q2 2021 to a low of -$3.5 million in Q1 2023.
- Historically, Other Gross PP&E Adjustments has averaged -$1.4 million across 5 years, with a median of -$1.3 million in 2024.
- Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 168.42% in 2021 and later crashed 308.71% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$1.2 million in 2021, then soared by 58.98% to -$473100.0 in 2022, then plummeted by 308.71% to -$1.9 million in 2023, then grew by 24.44% to -$1.5 million in 2024, then soared by 35.73% to -$939000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for VTGN at -$939000.0 in Q4 2025, -$1.1 million in Q3 2025, and -$1.2 million in Q2 2025.